SSY Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LJUIF research report →
Companywww.ssygroup.com.hk
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials.
- CEO
- Jiguang Qu
- IPO
- 2015
- Employees
- 6,146
- HQ
- Wan Chai, HK
Price Chart
Valuation
- Market Cap
- $1.19B
- P/E
- 14.69
- P/S
- 1.68
- P/B
- 0.95
- EV/EBITDA
- 8.92
- Div Yield
- 3.38%
Profitability
- Gross Margin
- 41.56%
- Op Margin
- 15.10%
- Net Margin
- 11.30%
- ROE
- 6.46%
- ROIC
- 4.51%
Growth & Income
- Revenue
- $4.16B · -27.87%
- Net Income
- $470.53M · -55.66%
- EPS
- $0.16 · -55.56%
- Op Income
- $406.15M
- FCF YoY
- 706.91%
Performance & Tape
- 52W High
- $0.70
- 52W Low
- $0.40
- 50D MA
- $0.40
- 200D MA
- $0.42
- Beta
- 0.46
- Avg Volume
- 341
Get TickerSpark's AI analysis on LJUIF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LJUIF Coverage
We haven't published any research on LJUIF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LJUIF Report →